Skip to content

Xtant Medical Holdings XTNT Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin62.9%+4.8pp58.2%-2.6pp60.8%+5.3pp55.4%-3.4pp
Net margin3.7%+17.7pp-14%-14.6%-5.9pp
Returns
Return on equity10.6%+45.5pp-34.9%-26.1%-4.7pp
Return on invested capital13.5%+32.9pp-19.5%+2.7pp-22.2%+3.3pp-25.5%-11.8pp
Efficiency
Asset turnover1.4×+0.2×1.3×+0.1×1.2×+0.2×-0.1×
Liquidity
Current ratio2.7×+0.3×2.3×-0.5×2.8×-0.4×3.2×-0.8×
Leverage
Debt-to-equity0.4×-0.2×0.5×+0.2×0.4×0.0×0.4×0.0×
Net debt / EBITDA
Per Share
Book value per share$0.34+5.7%$0.32-20.6%$0.41+11.5%$0.36+0.5%
Valuation
Market capitalization$59.05M-32.5%$61.58M-58.1%$147.02M+105%$71.72M+47.5%
Price / earnings32.3×
Price / sales0.5×-0.2×0.5×-1.1×1.6×+0.4×1.2×+0.4×
Price / book1.2×-0.6×1.4×-1.4×2.9×+0.8×2.1×+0.5×
EV / EBITDA5.4×-17.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Xtant Medical Holdings's profit margins?
Xtant Medical Holdings (XTNT) runs a 62.3% gross margin and a 4.8% operating margin, with a 1.5% net margin.
Where do Xtant Medical Holdings's ratios come from?
Every ratio is computed from Xtant Medical Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.